New drug APAC aims to prevent blood clots in leg artery patients
Disease control
Recruiting now
This study tests a new drug called APAC, which is designed to prevent blood clots in people with blocked leg arteries. The trial includes 42 adults with peripheral arterial disease or chronic limb-threatening ischemia. Researchers will check if APAC is safe and well-tolerated, an…
Phase: PHASE2 • Sponsor: Aplagon Oy • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC